387 related articles for article (PubMed ID: 15761153)
1. High-throughput mapping of a dynamic signaling network in mammalian cells.
Barrios-Rodiles M; Brown KR; Ozdamar B; Bose R; Liu Z; Donovan RS; Shinjo F; Liu Y; Dembowy J; Taylor IW; Luga V; Przulj N; Robinson M; Suzuki H; Hayashizaki Y; Jurisica I; Wrana JL
Science; 2005 Mar; 307(5715):1621-5. PubMed ID: 15761153
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity.
Ozdamar B; Bose R; Barrios-Rodiles M; Wang HR; Zhang Y; Wrana JL
Science; 2005 Mar; 307(5715):1603-9. PubMed ID: 15761148
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
4. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
5. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
8. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Zhang Y; Feng X; We R; Derynck R
Nature; 1996 Sep; 383(6596):168-72. PubMed ID: 8774881
[TBL] [Abstract][Full Text] [Related]
9. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.
Hocevar BA; Smine A; Xu XX; Howe PH
EMBO J; 2001 Jun; 20(11):2789-801. PubMed ID: 11387212
[TBL] [Abstract][Full Text] [Related]
10. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
12. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
13. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
14. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
15. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
16. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
17. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
[TBL] [Abstract][Full Text] [Related]
18. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
19. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
[TBL] [Abstract][Full Text] [Related]
20. Vectorial TGFbeta signaling in polarized intestinal epithelial cells.
Yakovich AJ; Huang Q; Du J; Jiang B; Barnard JA
J Cell Physiol; 2010 Aug; 224(2):398-404. PubMed ID: 20432436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]